Nancy B. Gardiner’s Novo Nordisk NVO Stock Holding History

Nancy B. Gardiner’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$311K	Hold	9,500	–	–	0.51%	56
2020 Q1	$286K	Hold	9,500	–	–	0.58%	55
2019 Q4	$275K	Hold	9,500	–	–	0.44%	62
2019 Q3	$246K	Hold	9,500	–	–	0.42%	65
2019 Q2	$242K	Hold	9,500	–	–	0.4%	66
2019 Q1	$248K	Hold	9,500	–	–	0.42%	65
2018 Q4	$219K	Hold	9,500	–	–	0.44%	63
2018 Q3	$224K	Hold	9,500	–	–	0.39%	67
2018 Q2	$219K	Sell	9,500 -620	-6%	-$14.7K	0.65%	44
2018 Q1	$249K	Hold	10,120	–	–	0.74%	38
2017 Q4	$272K	Hold	10,120	–	–	0.76%	37
2017 Q3	$244K	Sell	10,120 -1,158	-10%	-$26.2K	0.45%	48
2017 Q2	$242K	Sell	11,278 -900	-7%	-$18.2K	0.49%	47
2017 Q1	$208K	Sell	12,178 -200	-2%	-$3.48K	0.48%	51
2016 Q4	$222K	Hold	12,378	–	–	0.56%	48
2016 Q3	$257K	Sell	12,378 -98	-0.8%	-$2.43K	0.66%	49
2016 Q2	$336K	Buy	12,476 +1,256	+11%	+$34.4K	1.08%	38
2016 Q1	$304K	Buy	11,220 +1,100	+11%	+$29.5K	1.31%	33
2015 Q4	$294K	Buy	+10,120	New	+$280K	1.43%	31

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

Nancy B. Gardiner's NVO Position: Q2 2020 in Review

Nancy B. Gardiner held its Novo Nordisk (NVO) position steady in Q2 2020 at 9,500 shares worth $311K. The position accounts for 0.51% of the portfolio, ranked #56.

Nancy B. Gardiner first reported a position in NVO in Q4 2015 and has held it in 19 quarters since. The position peaked at $336K in Q2 2016. 661 funds tracked by Wall St. Rank hold NVO as of Q2 2020.

Nancy B. Gardiner held 9,500 shares of Novo Nordisk worth $311K as of Q2 2020.
Nancy B. Gardiner left its Novo Nordisk share count unchanged in Q2 2020.
Novo Nordisk made up 0.51% of Nancy B. Gardiner's portfolio in Q2 2020, its #56 holding.
Nancy B. Gardiner first reported a position in Novo Nordisk in Q4 2015 and has held it in 19 quarters since.
Nancy B. Gardiner's Novo Nordisk position peaked at $336K in Q2 2016.
661 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2020.

Based on Nancy B. Gardiner's 13F filing for Q2 2020, filed 28 Jul 2020.